Enzymatically Forming Intranuclear Peptide Assemblies for Selectively Killing Human Induced Pluripotent Stem Cells

Shuang Liu1,2, Qiuxin Zhang1, Adrianna N Shy1

  • 1Department of Chemistry, Brandeis University, 415 South Street, Waltham, Massachusetts 02454, United States.

Insights

A novel phosphopentapeptide selectively eliminates undifferentiated human induced pluripotent stem cells (iPSCs) by forming intranuclear assemblies. This targeted approach offers a promising strategy for safe iPSC clinical applications by avoiding normal cell toxicity.

Area of Science:

  • Biochemistry
  • Stem Cell Biology
  • Nanotechnology

Background:

  • Tumorigenic risk of undifferentiated human induced pluripotent stem cells (iPSCs) hinders clinical translation.
  • Selective elimination of undifferentiated iPSCs is crucial for safe cell-based therapies.

Purpose of the Study:

  • To develop a novel method for selectively eliminating undifferentiated iPSCs.
  • To investigate the mechanism of peptide assembly formation and cell targeting.

Main Methods:

  • Synthesis of an l-phosphopentapeptide with self-assembly properties.
  • Enzymatic dephosphorylation by alkaline phosphatase (ALP) overexpressed in iPSCs.
  • Characterization of peptide assembly morphology (micelles, nanofibers) using circular dichroism and FTIR.
  • Assessment of iPSC viability and normal cell toxicity.

Main Results:

  • The phosphopentapeptide forms intranuclear α-helical assemblies in iPSCs upon ALP-catalyzed dephosphorylation, leading to rapid cell death (<2 h).
  • Normal cells lacking significant ALP expression are unaffected, demonstrating high selectivity.
  • Assembly formation is dependent on ALP activity, phosphotyrosine position, and leucine chirality.

Conclusions:

  • Enzymatic noncovalent synthesis enables selective targeting of cell nuclei via intranuclear peptide assemblies.
  • This approach provides a novel strategy for eliminating undifferentiated iPSCs, addressing a key barrier to their clinical use.
  • The findings may extend to targeting other pathological cells overexpressing specific enzymes.

Related Concept Videos

Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.0K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.7K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.9K